What is GLP-1 skincare and does it really work?

Few could have anticipated that a class of drugs developed to treat metabolic disease would create an entirely new conversation in beauty. As GLP-1s have transformed weight management, significant weight loss can mean diminished volume on the face and a more hollow appearance. “Ozempic face” may be an inelegant term, but it has given skincare an unexpected new frontier: addressing the aesthetic aftermath of a medical revolution.

THE FACIAL SHIFT

“When someone experiences rapid weight loss on GLP-1 medications, the body sheds fat from the deep, structural fat pads in the face that act as our natural cushion,” explains Dr Jamuna Pai, cosmetic physician, author, and Founder of SkinLab. “Simultaneously, because the weight drop happens so quickly, the skin’s natural collagen and elastin matrix don’t have enough time to contract and adapt. At a tissue level, this leads to structural deflation.”

The phenomenon is not exclusive to GLP-1s. Similar changes can follow bariatric surgery or extreme dieting. “GLP-1 skin” is not an official medical condition, says Dr Noopur Jain, Founder and Consultant Dermatologist at Skinzest. “The important distinction is that many of these changes are related to rapid weight loss itself rather than being a direct effect of the GLP-1 medication.” How pronounced they are depends on several factors, including age, genetics, facial anatomy, baseline skin quality, nutrition, and the amount and pace of weight loss. Other concerns can accompany the change. “Hair loss is one of the more common concerns I hear,” says Dr Geetika Srivastava, dermatologist and Founder of Influennz Clinic. “Patients also frequently report dryness, dullness, and a general loss of skin vitality, particularly as their dietary intake changes during weight loss.”

This is where skincare has a role to play, albeit a measured one. “Topical skincare works well on the epidermal-dermal junction,” says Pai. “It can significantly improve surface hydration, smooth out a crepey texture.” What it cannot do is replace what has been lost beneath the skin. “Products cannot penetrate deep enough into the subcutaneous layers to rebuild lost fat pads or fix severe structural sagging,” says Pai.

For the concerns that do sit within its reach, Srivastava points to “peptides, Centella asiatica, copper peptides, and hyaluronic acid,” particularly for barrier support and inflammation.

Jain advocates a less trend-driven approach. “I would focus on ingredients and technologies that already have evidence behind them rather than looking for a ‘magic’ ingredient specifically for GLP-1 skin,” she points out. Their efficacy does not fundamentally change simply because GLP-1s enter the equation. “There is currently no accepted medical definition of what makes a product ‘GLP-1 skincare’,” says Jain. “If a formulation is designed to improve hydration, support the skin barrier, improve texture, or address lines, those concerns can occur in anyone—not only people taking GLP-1 medications.”

BEYOND THE LABEL

The category’s commercial appeal, meanwhile, is difficult to overlook. As more people undergo significant weight loss, brands have been quick to position products around its visible effects. “Many brands are jumping on a trending keyword to capture a fresh market segment,” adds Pai.

Srivastava sees an opportunity for the category to become more considered. “Ideally, I would like to see skincare evolve beyond simply addressing surface-level concerns,” she says. The more meaningful shift, then, may be towards formulations designed around the 

demands of significant weight loss rather than products claiming to treat “GLP-1 skin” as a distinct condition. When the concern is structural, however, the beauty shelf has its limits. “Once there is early or established sagging, I generally look at procedures such as HIFU or, in selected cases, thread lifts,” says Srivastava. Pai recommends in-clinic options where there is “structural hollowing or visible skin laxity such as drooping jowls, deepening nasolabial folds, or a hollowed under-eye area that topicals simply cannot fix.” Neither dermatologist, however, considers GLP-1 use itself an indication for intervention. Jain’s philosophy is ‘less is more’. “The objective should not be to treat someone simply because they have taken a GLP-1 medication,” she says. “We should assess what has actually changed.”

THE BIGGER PICTURE

What happens during weight loss matters as much as what is applied afterwards. “Consuming adequate high-quality protein, staying well-hydrated, and taking targeted micronutrients provides the necessary amino acids and building blocks your body needs to maintain collagen synthesis and hair follicle health,” says Pai.

Srivastava takes a similarly measured approach, aiming for sustainable weight loss of around 0.5 to 1kg per week in her practice and monitoring body composition to track changes in muscle and fat mass.

The phrase “GLP-1 skincare” may have arrived quickly, but the concerns behind it are not entirely new. What has changed is the scale of attention around them. The credible response is unlikely to be another miracle cream, but skincare that understands what it can improve, what it cannot, and when the difference requires more than a product.

This article originally appeared in Harper's Bazaar India's August - September 2026 print issue.

Image credits: Getty Images

Also read: What if your cleanser could double up as a brightening mask?

Also read: Meet the retinal serums changing the retinoid conversation